Down-regulated expression of the CCAAT/enhancer binding protein α and β genes in human hepatocellular carcinoma: A possible prognostic marker

Anticancer Research

Volumn 23, Issue 1 A, 2003, Pages 351-354

  Tomizawa, Minoru ^a,b   Watanabe, Kazuo ^a   Saisho, Hiromitsu ^b   Nakagawara, Akira ^a   Tagawa, Masatoshi ^a  

^a CHIBA CANCER CENTER   (Japan)

^b CHIBA UNIVERSITY   (Japan)

Author keywords

C EBP ; C EBP ; Hepatocellular carcinoma; Quantitative real time PCR

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN ALPHA; CCAAT ENHANCER BINDING PROTEIN BETA; TRANSCRIPTION FACTOR; TUMOR MARKER;

ARTICLE; CANCER GROWTH; CANCER SIZE; CANCER STAGING; CANCER SURVIVAL; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION REGULATION; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS;

CARCINOMA, HEPATOCELLULAR; CCAAT-ENHANCER-BINDING PROTEIN-ALPHA; CCAAT-ENHANCER-BINDING PROTEIN-BETA; DISEASE PROGRESSION; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIVER NEOPLASMS; NEOPLASM STAGING; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 0344837364     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Matsumata T, Kanematsu T, Shirabe K, Sonoda T, Furuta T and Sugimachi K: Decreased morbidity and mortality rates in surgical patients with hepatocellular carcinoma. Br J Surg 77: 677-680, 1990.
2. The Liver Cancer Study Group of Japan: Primary liver cancer in Japan. Clinicopathlogic features and results of surgical treatment. Ann Surg 211: 277-290, 1990.
3. Takiguchi M: The C/EBP family of transcription factors in the liver and other organs. Int J Exp Path 79: 369-391, 1998.
4. Flodby P, Antonson P, Barlow C, Blanck A, Porsch-Hälstrom I and Xanthopoulos KG: Differential patterns of expression of three C/EBP isoforms, HNF-1, and HNF-4 after partial hepatectomy in rats. Exp Cell Res 208: 248-256, 1993.
5. Flodby P, Liao DZ, Blanck A, Xanthopoulos KG and Hällström IP: Expression of the liver-enriched transcription factors C/EBPα, C/EBPβ, and HNF-4 in preneoplastic nodules and hepatocellular carcinoma in rat liver. Mol Carcinogenesis 12: 103-109, 1995.
6. Flodby P, Barlow C, Kylerford H, Ährlund-Richter L and Xanthopoulos KG: Increased hepatic cell proliferation and lung abnormalities in mice deficient in CCAAT/enhancer binding protein α. J Biol Chem 271: 24753-24760, 1996.
7. Soriano HE, Kang DC, Finegold MJ, Hicks MJ, Wang ND, Harrison W and Darlington GJ: Lack of C/EBP alpha gene expression results in increased DNA synthesis and an increased frequency of immortalization of freshly isolated mice hepatocytes. Hepatology 27: 392-401, 1998.
8. Greenbaum LE, Li W, Cressman DE, Peng Y, Ciliberto G, Poli V and Taub R: CCAAT enhancer-binding protein β is required for normal hepatocyte proliferation in mice after partial hepatectomy. J Clin Invest 102: 996-1007, 1998.
9. Shen CN, Slack JMW and Tosh D: Molecular basis of transdifferentiation of pancreas to liver. Nature Cell Biol 2: 879-887, 2000.
10. Halmos B, Huettner CS, Kocher O, Ferenzi K, Karp DD and Tenen DG: Down-regulation and antiproliferative role of C/EBPα in lung cancer. Cancer Res 62: 528-534, 2002.
11. Perrotti D, Cesi V, Trotta R, Guerzoni C, Santilli G, Campbell K, Iervolino A, Condorelli F, Gambacorti-Passerini C, Caligiuri MA and Calabretta B: BCR-ABL suppresses C/EBPα expression through inhibitory action of hnRNP E2. Nat Genet 30: 48-58, 2002.
12. Xu L, Hui L, Wang S, Gong J, Jin Y, Wang Y, Ji Y, Wu X, Han Z and Hu G: Expression profiling suggested a regulatory role of liverenriched transcription factors in human hepatocellular carcinoma. Cancer Res 61: 3176-3181, 2000.
13. Rask K, Thörn M, Pontén F, Kraaz W, Sundfeld K, Hedin L and Enerbäck S: Increased expression of the transcription factors CCAAT-enhancer binding prtein-β (C/EBPβ) and C/EBPζ (CHOP) correlate with invasiveness of human colorectal cancer. Int J Cancer 86: 337-343, 2000.
14. Sundfeldt K, Ivarsson K, Carlsson M, Enerbäck S, Janson PO, Brännström M and Heldin L: The expression of CCAAT/enhancer binding protein (C/EBP) in the human ovary in vivo: specific increase in C/EBPβ during epithelial tumour progression. Br J Cancer 79: 1240-1248, 1999.
15. Buck M, Turler H and Chojkier M: LAP (NF-IL6), a tissue-specific transcriptional activator, is an inhibitor of hepatoma cell proliferation. EMBO J 13: 851-860, 1994.
16. Inagawa S, Itabashi M, Adachi S, Kawamoto T, Hori M, Shimazaki J, Yoshimi F and Fukao K: Expression and prognostic roles of β-catenin in hepatocellular carcinoma: correlation with tumor progression and postoperative survival. Clin Cancer Res 8: 450-456, 2002.
17. Shichiri M, Yoshinaga K, Hisatomi H, Sugihara K and Hirata Y: Genetic and epigenetic inactivation of mitotic checkpoint genes hBUB and hBUBR1 and their relationship to survival. Cancer Res 62: 13-17, 2002.
18. Sasaki Y, Yamamura H, Kawakami Y, Yamada T, Hiratsuka M, Kameyama M, Ohigashi H, Ishikawa O, Imaoka S, Ishiguro S and Takahashi K: Expression of smooth muscle calponin in tumor vessels of human hepatocellular carcinoma and its possible association with prognosis. Cancer 94: 1777-1786, 2002.
19. Liu SH, Lin CY, Peng SY, Jeng YM, Pan HW, Lai PL, Liu CL and Hsu HC: Down-regulation of Annexin A10 in hepatocellular carcinoma is associated with vascular invasion, early recurrence, and poor prognosis in synergy with p53 mutation. Am J Pathol 160: 1831-1837, 2002.